Abstract GS5-01: Addition of platinum to sequential taxane-anthracycline neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial
Sudeep Gupta(Homi Bhabha National Institute), Rajendra Badwe(Tata Memorial Hospital), Rajiv Sarin(Homi Bhabha National Institute), Garvit Chitkara(Tata Memorial Hospital), Tejal Panhale(Tata Memorial Hospital), Nita Nair(Tata Memorial Hospital), Shalaka Joshi(Tata Memorial Hospital), Vaibhav Vanmali(Tata Memorial Hospital), Tanuja Shet(Tata Memorial Hospital), Jaya Ghosh(Homi Bhabha National Institute), Asawari Patil(Tata Memorial Hospital), Tabassum Wadasadawala(Homi Bhabha National Institute), Jyoti Bajpai(Homi Bhabha National Institute), Seema Gulia(Tata Memorial Hospital), Rohini Hawaldar(Tata Memorial Hospital), Sushmita Rath(Homi Bhabha National Institute), Vani Parmar(Homi Bhabha National Institute), Sangeeta Desai(Tata Memorial Hospital), Meenakshi Thakkur(Tata Memorial Hospital)
Cited by 23
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016
|The Lancet Oncology|2018|488